INTS Intensity Therapeutics, Inc.
$3.20▼ -1.54%
Healthcare
Other
Volume 10.3K
Avg Volume (10D) 23.3K
Key Metrics & Fundamentals
Market Cap
$10.45M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.00 - 43.50
% vs 50 MA
-16.89%
% vs 200 MA
-40.37%
RSI-14
38.1
MACD Histogram
+0.0000
Beta (1Y vs SPY)
-1.72
Free Cash Flow
-$2.34M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.08M
COGS
–
Operating Exp
$3.08M
Operating Income
-$3.08M
EBIT
-$3.08M
Pretax Income
-$3.01M
Net Income
-$3.01M
EPS (Diluted)
-1.11
Price & Volume History
Loading chart…
Recent News
Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting
PR Newswire · Oct 23, 2026 8:00 AM ET
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 8, 2026 8:00 AM ET
Intensity Therapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 11, 2026 10:22 PM ET
Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 9:57 PM ET
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
PR Newswire · Aug 11, 2026 7:30 AM ET
Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
PR Newswire · Aug 4, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See INTS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.